01-Jul-16 Biotechnology is one of seven strategic industries that the Chinese government designated in the 13th Five-Year Plan. "Made in China 2025", an initiative to upgrade industry, also designates biotechnology as a key industry to push economic development. China's bio-pharmaceutical market is expected to reach USD601 bn by 2020. [image: China Daily]

28-Jun-16 Following the discovery of a counterfeit vaccine ring in the city, Jakarta is deploying personnel to raid private hospitals and clinics to ensure none of them use fake medications. The police have cracked down on counterfeit production and distribution in West Java, Jakarta and Banten and have discovered fake measles, polio, tuberculosis, tetanus and hepatitis B vaccines. [image: WorldNews Network]

28-Jun-16 Pfizer Inc will invest USD350 mn to build a biotech center in China, the latest in move by pharma industry giants to set up in the world's no.2 drugs market, with the aim of securing faster approvals for products. The facility in Hangzhou - Pfizer's first biotech center in Asia - is expected to be completed by 2018. [image: Reuters / Andrew Kelly]

09-Jun-16 Basic healthcare is becoming less accessible to ordinary Russians. Medicine sales have fallen for the first time in Russia since 2008: Analysts recorded a 10% drop in drug sales in the first quarter of 2016. During a severe economic crisis, a growing number of Russians can no longer afford to buy medicine. [image: Andrei Iglov / RIA Novosti]

31-May-16 Singapore-based Imagene Labs and New York-based LifeNome Inc have announced a partnership to bring genomic personalization to Southeast Asia. The partnership will leverage on the genetics testing facilities of Imagene Labs together with the proprietary bioinformatics platform of LifeNome, to provide consumers in the region with personalized guidance on nutrition, fitness, skincare and other wellness topics. [image: Pulse / LinkedIn]